glp-1 drugs and muscle loss can cause loss—but not in the way most critics claim. Research shows that while taking GLP-1 drugs, lean mass makes up about 20–30% of total weight loss, with the Glucagon-like peptide-1 receptor agonists and
Description
Achieve Sustainable Results With Personalized Care.

Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

This article explores the science behind these agents.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeuti...
Most users see best results with consistent, daily use over 812 weeks
Cinnamon (Cinnamomum verum) A warming spice used in Ayurveda for digestion, cinnamon may help improve insulin sensitivity and support GLP-1 activity after meals
